| Annual · values | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | -1.89 M USD | 1.58 M USD | 400238 USD | 1.24 M USD |
| Depreciation & Amortization | 289264 USD | 347977 USD | 367029 USD | 388233 USD |
| Stock-Based Compensation | 5.14 M USD | — | — | — |
| Capital Expenditures | 192531 USD | 25759 USD | 219121 USD | 18165 USD |
| Cash Flow from Investing | -204157 USD | 320644 USD | -218132 USD | -18165 USD |
| Cash Flow from Financing | 6.87 M USD | 224396 USD | 463463 USD | -1.72 M USD |
| Dividends Paid | — | — | — | — |
| Stock Buybacks | — | — | — | — |
| Free Cash Flow | -2.08 M USD | 1.55 M USD | 181117 USD | 1.22 M USD |
Inlife Ltd. is a company specializing in the development, production, and distribution of health and wellness products. Its primary function is to provide consumers with supplements and related health products designed to enhance overall well-being and address specific health concerns. Inlife Ltd. serves various sectors, including dietary supplements, sports nutrition, and healthcare, playing a key role in the consumer health industry. The company's offerings often include vitamins, minerals, herbs, and functional nutrition products, aligning with consumer preferences for natural and science-backed wellness solutions. Inlife Ltd. impacts the healthcare and lifestyle markets by promoting preventive health measures and supporting active, wellness-oriented lifestyles. Its presence is significant in regions where awareness and demand for health supplements are rising, contributing to broader trends in health-conscious consumer behavior. Through its innovative approach to product development and market reach, Inlife Ltd. supports the growing emphasis on integrated health management and personalized wellness solutions.